Latent Membrane Protein-1 Protein Induction toward Vascular Endothelial Growth Factor Expression in the Development of Nasopharyngeal Carcinoma

  • Jessy Chrestella Department of Pathology, Faculty of Medicine, Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
  • Farhat Farhat Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
  • Elvita Rahmi Daulay Department of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
  • Sheba Tarigan Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
  • Raudah Putri Syari Faculty of Medicine, Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
Keywords: nasopharyngeal carcinoma, immunohistochemistry, VEGF, EBV, LMP-1 protein

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is associated with Epstein–Barr virus infection as the main factor. Latent membrane protein (LMP)-1 protein and vascular endothelial growth factor (VEGF) have been suggested as the prognostic biomarker for NPC.

AIM: This study is conducted to analyze the overexpression of LMP-1 protein and VEGF and the combination of these two in NPC patients. The role of LMP-1 protein in the induction of VEGF is identified by analyzing the association between these two proteins.

METHODS: A cross-sectional design study is conducted at Adam Malik General Hospital. Formalin-fixed, paraffin-embedded sections from the NPC tissue samples are submitted for immunohistochemistry staining. Fisher’s exact test is used to analyze variables relation.

RESULTS: Among 56 samples, there was a significant correlation between LMP-1 protein overexpression with histopathological type and clinical staging, and VEGF overexpression with lymph node enlargement and clinical staging (p < 0.05). There was no significant correlation between LMP-1 protein with VEGF in NPC patients (p > 0.05).

CONCLUSION: Increased expressions of LMP-1 protein, VEGF, and a combination of LMP-1 protein and VEGF are noted in correlation with increasing the clinical stages. In contrast to the previously suggested hypotheses, the correlation between these two proteins is not significant in the present study. It could happen due to the different associations of each protein overexpression toward the clinical parameter. However, these two proteins could be used in evaluating the prognosis and providing a targeted therapy to NPC.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Mahdavifar N, Towhidi F, Makhsosi BR, Pakzad R, Moini A, Ahmadi A, et al. Incidence and mortality of nasopharynx cancer and its relationship with human development index in the world in 2012. World J Oncol. 2016;7(5-6):109. https://doi. org/10.14740/wjon980w PMid:28983375

Zeng MS, Zeng YX. Pathogenesis and Etiology of Nasopharyngeal Carcinoma. Nasopharyngeal Cancer. Berlin, Germany: Springer; 2010. p. 9-25.

Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33(8):381. PMid:25096544

Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012-24. https://doi.org/10.1016/ s0140-6736(15)00055-0 PMid:26321262

Huang S, Tsao S, Tsang C. Interplay of viral infection, host cell factors and tumor microenvironment in the pathogenesis of nasopharyngeal carcinoma. Cancers. 2018;10(4):106. https:// doi.org/10.3390/cancers10040106 PMid:29617291

Gourzones C, Busson P, Raab-Traub N. Epstein-barr Virus and the Pathogenesis of Nasopharyngeal Carcinomas. Nasopharyngeal Carcinoma. Berlin, Germany: Springer; 2013. p. 42-60. https://doi.org/10.1007/978-1-4614-5947-7_4

Tulalamba W, Janvilisri T. Nasopharyngeal carcinoma signaling pathway: An update on molecular biomarkers. Int J Cell Biol. 2012;2012:10. https://doi.org/10.1155/2012/594681

Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, et al. Pathogenic role of epstein-barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett. 2013;337(1):1-7. https://doi. org/10.1016/j.canlet.2013.05.018 PMid:23689138

Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D, et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med. 2008;6(1):1. https:// doi.org/10.1186/1479-5876-6-1 PMid:18171482

Kim TJ, Lee YS, Kang JH, Kim YS, Kang CS. Prognostic significance of expression of vegf and cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR. J Surg Oncol. 2011;103(1):46-52. https://doi. org/10.1002/jso.21767 PMid:21031415

Yang G, Deng Q, Fan W, Zhang Z, Xu P, Tang S, et al. Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma. PLoS One. 2017;12(3):e0173641. https://doi.org/10.1371/journal. pone.0173641 PMid:28301518

Huang D, Song SJ, Wu ZZ, Wu W, Cui XY, Chen JN, et al. Epstein-barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res. 2017;77(13):3591-604. https://doi.org/10.1158/0008-5472.can-16-2706 PMid:28484077

Stevenson D, Charalambous C, Wilson JB. Epstein-barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGFα concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res. 2005;65(19):8826-35. https://doi. org/10.1158/0008-5472.can-05-0591

Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. Epstein-barr virus-encoded LMP-1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol. 2008;82(7):3654-64. https://doi.org/10.1128/jvi.01888-07 PMid:18199641

Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, et al. Epstein-barr virus encoded LMP-1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res. 2013;32(1):90. https://doi.org/10.1186/1756-9966-32-90 PMid:24499623

Zheng H, Li L, Hu D, Deng X, Cao Y. Role of epstein-barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007;4(3):185-96. PMid:17601372

You S, Zhang F, Meng F, Li H, Liu Q, Liang Y, et al. EBV-encoded LMP-1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma. Tumor Biol. 2011;32(4):623-30. https://doi.org/10.1007/ s13277-011-0161-x PMid:21336584

Chew MM, Gan SY, Khoo AS, Tan EL. Interleukins, laminin and epstein-barr virus latent membrane protein 1 (EBV LMP-1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 2010;10(1):574. https://doi. org/10.1186/1471-2407-10-574. PMid:20964870

Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, et al. STAT3 activation induced by epstein-barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 2010;46(16):2996-3006. https://doi.org/10.1016/j. ejca.2010.07.008 PMid:20709526

Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, et al. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP-1-positive exosomes. Oncogene. 2014;33(37):4613. https://doi.org/10.1038/onc.2014.66 PMid:24662828

Wang A, Zhang W, Jin M, Zhang J, Li S, Tong F, et al. Differential expression of EBV proteins LMP-1 and BHFR1 in EBV associated gastric and nasopharyngeal cancer tissues. Mol Med Rep. 2016;13(5):4151-8. https://doi.org/10.3892/ mmr.2016.5087

Borthakur P, Kataki K, Keppen C, Khamo V, Medhi S, Deka M. Expression of epstein barr virus encoded EBNA1 and LMP-1 oncoproteins in nasopharyngeal carcinomas from Northeast India. Asian Pac J Cancer Prev. 2016;17(7):3411-6. PMid:27509984

Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, et al. Expression of epstein-barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): A clinicopathological study. Arch Med Res. 2014;45(3):229-36. https://doi.org/10.1016/j. arcmed.2014.02.002 PMid:24606815

Tabyaoui I, Serhier Z, Sahraoui S, Sayd S, Cadi R, Bennani O, et al. Immunohistochemical expression of latent membrane protein 1 (LMP-1) and p53 in nasopharyngeal carcinoma: Moroccan experience. Afr Health Sci. 2013;13(3):710-7. https:// doi.org/10.4314/ahs.v13i3.27 PMid:24250311

Kurnianda J, Hardianti MS, Harijadi TH, Purwanto I, Haryana SM, Tjokronagoro M. Elevation of vascular endothelial growth factor in Indonesian advanced stage nasopharyngeal carcinoma. Kobe J Med Sci. 2009;55(2):E36-44. PMid:20847590

Krishna SM, James S, Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res. 2006;115(1):85-90. https:// doi.org/10.1016/j.virusres.2005.07.010 PMid:16139912

Pan J, Tang T, Xu L, Lu JJ, Lin S, Qiu S, et al. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. Head Neck. 2013;35(9):1238-47. https://doi.org/10.1002/hed.23116 PMid:22972415

Xinhua X, Guoqing H, Song L, Feng X, Daojun L, Delan D, et al. Expression of cyclooxygenase-2 in nasopharyngeal carcinoma and its relation to angiogenesis and prognosis. Chin German J Clin Oncol. 2006;5(2):104-7.

Sha D, He YJ. Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma. Ai Zheng. 2006;25(2):229-34. PMid:16480593

Segawa Y, Oda Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S, et al. Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma. Oncol Rep. 2009;21(5):1197-202. https://doi. org/10.3892/or_00000341 PMid:19360294

Paydas S, Ergin M, Erdogan S, Seydaoglu G. Prognostic significance of EBV-LMP-1 and VEGF-A expressions in non-hodgkin’s lymphomas. Leuk Res. 2008;32(9):1424-30. https:// doi.org/10.1016/j.leukres.2008.01.008

Xu S, Bai J, Zhuan Z, Li B, Zhang Z, Wu X, et al. EBV LMP-1 is involved in vasculogenic mimicry formation via VEGFA/ VEGFR1 signaling in nasopharyngeal carcinoma. Oncol Rep. 2018;40(1):377-84. https://doi.org/10.3892/or.2018.6414 PMid:29749553

Published
2020-03-26
How to Cite
1.
Chrestella J, Farhat F, Daulay ER, Tarigan S, Syari RP. Latent Membrane Protein-1 Protein Induction toward Vascular Endothelial Growth Factor Expression in the Development of Nasopharyngeal Carcinoma. Open Access Maced J Med Sci [Internet]. 2020Mar.26 [cited 2020Oct.29];8(B):368-74. Available from: https://www.id-press.eu/mjms/article/view/4640
Section
Ear, Nose and Throat